This website has been developed by ALK and is intended for healthcare professionals only. Jext® is indicated in the emergency treatment of severe acute allergic reactions (anaphylaxis) to insect stings or bites, foods, drugs and other allergens as well as idiopathic or exercise induced anaphylaxis. Prescribing Information UK ROI

  • Home
  • Resources
    • Resources
    • Order Literature
    • Jext®app
  • FAQs
Contact Us
Expiry Alert Service

Resources

There is a comprehensive range of resources aimed at supporting you and your patients for whom Jext® has been prescribed. Resources include the Jext® trainer and materials such as the Prescriber Checklist.

Download App

Order Literature

See the range of Jext® resources available for you to download or order online.

Learn more

Prescriber Checklist

Download the prescriber checklist
to ensure you are prescribing Jext® correctly for your patients.
The checklist includes points for consideration such as instructions
for use and storage.

UK Prescriber Checklist
ROI Prescriber Checklist

Action Plan

Does your patient get the support they need beyond your practice? Encourage them to download this emergency response Action Plan in their preferred language and the preferred language of the people responsible for their welfare, to ensure they are prepared in an emergency.

Download Now

How to Use

Jext® is easy to use and it is broken down into 5 main steps.

You can download the instruction leaflet in the patient’s preferred language below.

Download Now

Jext® app

People at risk of anaphylaxis need regular coaching in how to use adrenaline auto-injectors correctly and safely7. Tell your patients about the free Jext® app for iPhone and Android.

Features include:

  • Voice-guided instructions for use
  • Symptoms of anaphylaxis
  • Educational videos
  • Free expiry alert service
Learn more

January 2025
IE-JXT-2400014

Adverse events should be reported. Reporting forms and information can be found at www.mhra.gov.uk/yellowcard (for the United Kingdom) or www.hpra.ie (for Republic of Ireland).

Adverse events should also be reported to ALK-Abelló Ltd. Email: drugsafetyuk@alk.net Phone: +44(0)118 903 7940

Terms of Use
This site provides additional patient information to ONLY those patients who are currently prescribed Jext®. Any information contained in this site should not be acted upon without first consulting your doctor. Jext® is a registered trademark of ALK-Abelló Ltd.

Click below for:

Jext 150mcg SPC
UK ROI
Jext 300mcg SPC
UK ROI
Patient Information Leaflet
UK ROI

ALK-Abelló Ltd, 1 Manor Park,
Manor Farm Road,
Reading, Berkshire,
RG2 0NA

Tel: +44(0)118 903 7940

Email: infouk@alk.net

© Copyright 2025 ALK-Abelló LtdContact usDisclaimerPrivacy NoticeExpiry Alert Cancellation

January 2025
IE-JXT-2400021